Actively Recruiting
The Effects of 5G Radiation on Skin
Led by Prof. Olivier Gaide, MD-PhD · Updated on 2026-03-27
42
Participants Needed
1
Research Sites
138 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The current 5G waves used on the daily life are ranging from 410 MHz to 7125 MHz and are called FR1. The next deployed 5G waves will be FR2, from 24.45 GHz to 52.6 GHz. Our project targets the 27.5 GHz frequency, as it will be used in both Europe and the USA. Recent studies have shown that these 5G FR2 waves enter the skin but do not penetrate deeper in the body, which is why our project focuses on the skin. Our aim is to understand the effects of 5G waves on skin by performing a clinical trial. In this study, participants (healthy volunteers, patients with dermatoporosis, or whose skin is prone to developing cancer or who suffer from atopic dermatitis) will be exposed to carefully chosen 5G parameters and skin will be analyzed by state-of-the-art single cell RNA analysis (an unbiased and very sensitive technique ideal for studying cell behavior changes). This project will also decipher the differences between women and men, in response to 5G FR2 waves.
CONDITIONS
Official Title
The Effects of 5G Radiation on Skin
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants include healthy volunteers or those with dermatoporosis, Gorlin Goltz Syndrome (OMIM 10940014), Familial Cylindromatosis, SB Syndrome (OMIM 132700/60504114), XPV (OMIM 27875014), or atopic dermatitis
- Able to provide informed consent by signing
- Adults aged 18 to 80 years according to groups
You will not qualify if you...
- Recent intense sun exposure causing sunburn within the last 7 days
- Pregnant or lactating women (confirmed by pregnancy test)
- Patients taking anti-coagulant medications
- Clinically significant other diseases as judged by a skin specialist
- Currently enrolled in another clinical trial
- Participants unable to make informed decisions or under legal guardianship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHUV
Lausanne, Canton of Vaud, Switzerland, 1011
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here